{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:12:10Z","timestamp":1783357930951,"version":"3.54.6"},"reference-count":96,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ITT"],"DOI":"10.2147\/itt.s316602","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T06:50:21Z","timestamp":1650955821000},"page":"11-21","source":"Crossref","is-referenced-by-count":46,"title":["Immunotargets and Therapy for Prurigo Nodularis"],"prefix":"10.2147","volume":"Volume 11","author":[{"given":"Angelina","family":"Labib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3239-6121","authenticated-orcid":true,"given":"Teresa","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Vander Does","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.det.2018.02.003","volume":"36","author":"Zeidler","year":"2018","journal-title":"Dermatol Clin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/17512433.2021.1852080","volume":"14","author":"Williams","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref3","volume-title":"StatPearls","year":"2022"},{"key":"ref4","first-page":"5","volume":"26","author":"Leis","year":"2021","journal-title":"Skin Therapy Lett"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jaad.2016.05.035","volume":"75","author":"Mollanazar","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1468-3083.2012.04481.x","volume":"27","author":"Iking","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00403-020-02148-0","volume":"313","author":"Janmohamed","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40257-016-0215-3","volume":"17","author":"Silverberg","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"AB38","DOI":"10.1016\/j.jaad.2021.06.176","volume":"85","author":"Whang","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1016\/j.jaip.2020.05.051","volume":"8","author":"Whang","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jid.2019.07.697","volume":"140","author":"Huang","year":"2020","journal-title":"J Invest Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jdin.2020.10.009","volume":"2","author":"St\u00e4nder","year":"2021","journal-title":"JAAD Int"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1016\/j.jid.2021.02.756","volume":"141","author":"Wongvibulsin","year":"2021","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.jaad.2020.04.183","volume":"83","author":"Huang","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref15","first-page":"1","volume":"22","author":"M\u00fcller","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ejp.767","volume":"20","author":"Zeidler","year":"2016","journal-title":"Eur J Pain"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/exd.14279","volume":"30","author":"Hashimoto","year":"2021","journal-title":"Exp Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.3390\/jcm10091906","volume":"10","author":"Furue","year":"2021","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"adv00375","DOI":"10.2340\/00015555-3702","volume":"101","author":"Hashimoto","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.2174\/1570159X16666180412092859","volume":"16","author":"Rocco","year":"2018","journal-title":"Curr Neuropharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/ACI.0000000000000658","volume":"20","author":"Topal","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"594735","DOI":"10.3389\/fimmu.2020.594735","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.5114\/pdia.2015.56097","volume":"32","author":"Czarnecka-Operacz","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jid.2019.08.438","volume":"140","author":"Wong","year":"2020","journal-title":"J Invest Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jaad.2020.07.025","volume":"84","author":"Elmariah","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jaad.2020.04.182","volume":"83","author":"Williams","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.jaad.2019.01.052","volume":"80","author":"St\u00e4nder","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.anai.2020.05.028","volume":"126","author":"Erickson","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000446046","volume":"50","author":"Pereira","year":"2016","journal-title":"Curr Probl Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5070\/D3206022873","volume":"20","author":"Nakashima","year":"2014","journal-title":"Dermatol Online J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/bies.950180507","volume":"18","author":"Cato","year":"1996","journal-title":"Bioessays"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.iac.2005.05.003","volume":"25","author":"Barnes","year":"2005","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacol Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/jdv.14646","volume":"32","author":"Klejtman","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jaad.2018.09.020","volume":"80","author":"Qureshi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/ced.12365","volume":"39","author":"Spring","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1111\/jdv.17262","volume":"35","author":"Bergqvist","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00296-020-04694-2","volume":"40","author":"Misra","year":"2020","journal-title":"Rheumatol Int"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.7861\/futurehealth.6-2-s4","volume":"6","author":"Quah","year":"2019","journal-title":"Future Healthc J"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2018.09.027","volume":"158","author":"Wang","year":"2018","journal-title":"Eur J Med Chem"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5414\/CP203604","volume":"58","author":"Inose","year":"2020","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/acr2.11187","volume":"2","author":"Vanni","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5070\/D32311037244","volume":"23","author":"Cline","year":"2017","journal-title":"Dermatol Online J"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1610-0387.2008.06745.x","volume":"6","author":"Siepmann","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaad.2018.02.024","volume":"78","author":"Wiznia","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e13934","DOI":"10.1111\/dth.13934","volume":"33","author":"Amber","year":"2020","journal-title":"Dermatol Ther"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1172\/JCI200318384","volume":"111","author":"Maltzman","year":"2003","journal-title":"J Clin Invest"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jaad.2005.07.059","volume":"55","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaad.2015.05.025","volume":"73","author":"Maley","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Lear JT, English JS, Smith AG. Nodular prurigo responsive to azathioprine. Br J Dermatol. 1996;134(6):1151. doi:10.1111\/j.1365-2133.1996.tb07964.x","DOI":"10.1111\/j.1365-2133.1996.tb07964.x"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"716","DOI":"10.7326\/0003-4819-129-9-199811010-00007","volume":"129","author":"Black","year":"1998","journal-title":"Ann Intern Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e13222","DOI":"10.1111\/dth.13222","volume":"33","author":"Holm","year":"2020","journal-title":"Dermatol Ther"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2020.1853024","author":"Husein-ElAhmed","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"ref54","first-page":"940","volume":"18","author":"Tanis","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1001\/jamadermatol.2018.3912","volume":"155","author":"Beck","year":"2019","journal-title":"JAMA Dermatol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2021.1886232","author":"Toffoli","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/pde.14464","volume":"38","author":"Fachler","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"162","DOI":"10.18176\/jiaci.0550","volume":"31","author":"Romano","year":"2021","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e13201","DOI":"10.1111\/dth.13201","volume":"33","author":"Giura","year":"2020","journal-title":"Dermatol Ther"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1111\/ijd.14994","volume":"59","author":"Criado","year":"2020","journal-title":"Int J Dermatol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.1111\/jdv.15584","volume":"33","author":"Calugareanu","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/JAA.S300975","volume":"14","author":"Liu","year":"2021","journal-title":"J Asthma Allergy"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1001\/jamadermatol.2018.3906","volume":"155","author":"Mollanazar","year":"2019","journal-title":"JAMA Dermatol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3390\/medicines6030072","volume":"6","author":"Zhai","year":"2019","journal-title":"Medicines"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/jdv.15957","volume":"34","author":"Calugareanu","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/09546634.2019.1659479","volume":"32","author":"Ferrucci","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"e8737","DOI":"10.7759\/cureus.8737","volume":"12","author":"Wieser","year":"2020","journal-title":"Cureus"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jdcr.2019.03.016","volume":"5","author":"Rambhia","year":"2019","journal-title":"JAAD Case Rep"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jaad.2021.02.038","volume":"85","author":"Georgakopoulos","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ref70","unstructured":"Study of dupilumab for the treatment of patients with prurigo nodularis, inadequately controlled on topical prescription therapies or when those therapies are not advisable (PRIME2). Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04202679. Accessed April 11, 2022."},{"key":"ref71","unstructured":"Study of dupilumab for the treatment of patients with prurigo nodularis, inadequately controlled on topical prescription therapies or when those therapies are not advisable (LIBERTY-PN PRIME). Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04183335. Accessed April 11, 2022."},{"key":"ref72","unstructured":"Dupixent (dupilumab) is the first biologic to significantly reduce itch and skin lesions in Phase 3 trial for prurigo nodularis, demonstrating the role of type 2 inflammation in this disease [press release]. Sanofi; 2021. Available from: https:\/\/www.sanofi.com\/en\/media-room\/press-releases\/2021\/2021-10-22-07-00-00-2318876."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/jamadermatol.2019.3336","volume":"156","author":"Simpson","year":"2020","journal-title":"JAMA Dermatol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2019.07.074","volume":"82","author":"Deleuran","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s40257-020-00527-x","volume":"21","author":"Beck","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"638325","DOI":"10.3389\/fmed.2021.638325","volume":"8","author":"Kabashima","year":"2021","journal-title":"Front Med"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJMe1916733","volume":"382","author":"Kwatra","year":"2020","journal-title":"N Engl J Med"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1056\/NEJMoa1908316","volume":"382","author":"St\u00e4nder","year":"2020","journal-title":"N Engl J Med"},{"key":"ref79","author":"St\u00e4nder","year":"2021"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jaci.2021.10.004","volume":"149","author":"Tsoi","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"ref81","unstructured":"A study to evaluate the durability of response and safety of nemolizumab for 24 weeks in participants with prurigo nodularis. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05052983. Accessed April 11, 2022."},{"key":"ref82","unstructured":"An efficacy and safety study of nemolizumab (CD14152) in participants with prurigo nodularis. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04501666. Accessed April 11, 2022."},{"key":"ref83","unstructured":"A study to assess the efficacy and safety of nemolizumab (CD14152) in participants with Prurigo Nodularis (PN). Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04501679. Accessed April 11, 2022."},{"key":"ref84","unstructured":"A long-term study of nemolizumab (CD14152) in participants with Prurigo Nodularis (PN). Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04204616. Accessed April 11, 2022."},{"key":"ref85","unstructured":"Study to assess the efficacy, safety, and tolerability of vixarelimab in reducing pruritus in Prurigo Nodularis. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT03816891. Accessed April 11, 2022."},{"key":"ref86","author":"Howard Sofen","year":""},{"key":"ref87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1600-065X.2008.00742.x","volume":"228","author":"Gilfillan","year":"2009","journal-title":"Immunol Rev"},{"key":"ref88","unstructured":"A study of CDX-0159 in patients with Prurigo Nodularis. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT04944862. Accessed April 11, 2022."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12016-021-08880-3","volume":"61","author":"Li","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14709","author":"Agrawal","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/ced.14320","volume":"45","author":"Molloy","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.03.012","author":"Ju","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.det.2018.02.014","volume":"36","author":"Erickson","year":"2018","journal-title":"Dermatol Clin"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1001\/jamadermatol.2019.2855","volume":"155","author":"Gooderham","year":"2019","journal-title":"JAMA Dermatol"},{"key":"ref95","unstructured":"Efficacy of abrocitinib for reducing pruritus in adults with Prurigo Nodularis and chronic pruritus of unknown origin. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05038982. Accessed April 11, 2022."},{"key":"ref96","unstructured":"A study to evaluate the efficacy and safety of INCB054707 in participants with Prurigo Nodularis. Available from: https:\/\/ClinicalTrials.gov\/show\/NCT05061693. Accessed April 11, 2022."}],"container-title":["ImmunoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=80275","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=80275","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T06:50:31Z","timestamp":1650955831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/immunotargets-and-therapy-for-prurigo-nodularis-peer-reviewed-fulltext-article-ITT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":96,"URL":"https:\/\/doi.org\/10.2147\/itt.s316602","relation":{},"ISSN":["2253-1556"],"issn-type":[{"value":"2253-1556","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}